Telemedicine

AnsibleHealth is a virtual pulmonary rehabilitation and chronic care company delivering tech-enabled home-based healthcare for patients with COPD, congestive heart failure (CHF), and other chronic respiratory conditions. Founded in 2021 and based in Mountain View, California, the company provides virtual consultations with board-certified pulmonary specialists, personalized treatment plans, remote patient monitoring, exercise therapy, health education, smoking cessation support, and care coordination. Operating across all 50 states with multi-payer coverage including Medicare, Medicaid, and major commercial plans (Aetna, UnitedHealthcare, Humana, Anthem, Molina, and others), AnsibleHealth demonstrates strong clinical outcomes: 90% patient satisfaction, 82% symptomatic improvement, 103% increase in physical fitness (sit-to-stand), and 45% reduction in ER visits and hospitalizations. The clinician-led platform partners with top hospital systems (SOVAH Health, Sentara, Carilion Clinic, UVA Health) and employs team members from leading medical institutions and technology companies.

BrightInsight is a cloud-based digital health platform company serving biopharma and medtech organizations. The company specializes in developing and maintaining regulated digital health solutions, including Software as a Medical Device (SaMD), companion patient apps, connected medical devices, clinical algorithms, and healthcare provider interfaces. The BrightInsight Platform provides a configurable, enterprise-grade solution that enables faster time-to-market while ensuring compliance with global regulatory standards. The company has delivered 14 SaMD solutions across 11 therapy areas and partners with 6 of the top 10 biopharma firms. Core capabilities include real-world data collection, patient engagement tools, clinical outcome analytics, and disease management solutions. BrightInsight addresses the critical business need for regulated digital health deployment, helping life sciences companies differentiate therapies, improve patient adoption and retention, and unlock real-world evidence from connected digital health ecosystems.

Everly Health (formerly Everlywell) is a consumer health testing company based in Austin, Texas, offering at-home lab testing kits that enable individuals to conduct accessible, affordable health diagnostics without requiring a doctor's visit or prescription. The company operates a network of validated tests covering food sensitivity, allergy, hormone, STD, thyroid, cholesterol, and wellness biomarkers—over 30 offerings in total. Customers perform self-collection of samples at home, mail them to certified partner laboratories, and receive digital results within days. Following its 2017 Shark Tank appearance, Everlywell expanded to over 2,000 retail locations including Target and CVS. In 2021, the company consolidated operations by acquiring PWNHealth and Home Access Health to form Everly Health, broadening its service portfolio to include telehealth consultations via a national clinician network. The platform emphasizes proactive, preventative health management with easy-to-understand results and actionable health insights tailored to individual biomarkers.

Giddy Holdings is a sexual health company founded in 2017 and headquartered in Austin, Texas. The company operates a comprehensive B2C and B2B health platform combining FDA-cleared medical devices, telemedicine consultations, and clinical educational content. Giddy's flagship product is Eddie, an FDA Class II medical device for erectile dysfunction treatment, accompanied by structured digital learning programs and expert-developed guidance. The platform addresses sexual health conditions including erectile dysfunction, STDs/STIs, fertility, menopause, prostate health, endometriosis, and identity/sexuality topics. Giddy serves as both a consumer-facing e-commerce operation and clinical content authority, with three integrated brands: Giddy (educational content), Giddy Telehealth (remote consultations), and Eddie by Giddy (medical device and treatment). The company emphasizes inclusive, evidence-based health information and personalized recommendations across multiple sexual health conditions and life stages.

HeraMED Ltd is a Melbourne-based medical data and technology company specializing in AI-powered digital health solutions for women across their life stages, with particular focus on maternity care. The company's flagship HeraCARE platform provides remote monitoring, telehealth, customizable care plans, educational content, and AI-driven clinical decision support. The FDA-cleared HeraBEAT device enables home-based fetal and maternal heart rate monitoring. HeraMED's integrated solution combines an AI Clinician Dashboard for care providers (featuring ambient scribing, structured documentation, and centralized vitals/alerts) with an AI Virtual Companion patient app that delivers personalized education, symptom triage, and proactive engagement. The platform addresses fragmented women's healthcare by enabling continuous longitudinal monitoring across fertility, pregnancy, postpartum, menopause, and chronic conditions. Clinically validated through partnerships with Mayo Clinic and Broward Health, HeraMED demonstrates measurable outcomes including 50% reduction in postpartum readmissions, earlier detection of gestational hypertension, improved medication adherence, and reduced no-show rates. The solution serves maternity care deserts and underserved markets in Australia and the United States.

moveUP is a Belgium-based digital health SaaS platform founded in 2015, specializing in AI-driven digital therapeutics and remote patient monitoring solutions. The company delivers clinically validated digital patient support programs that enhance therapy compliance, automate triage, and enable real-time provider collaboration across multiple therapeutic domains. Core offerings include patient-facing mobile apps for education and treatment adherence, intuitive provider dashboards with integrated communication tools, automated clinical workflows, and real-world data collection and analytics capabilities. The moveUP Therapy platform utilizes adaptive AI algorithms that monitor over 400 patient data points to personalize pre- and post-hospital care journeys. The company serves hospitals, health systems, pharmaceutical manufacturers, and medical device companies primarily in orthopedics, bariatrics, oncology, cardiology, respiratory, neurology, dermatology, and hematology. Clients include major hospital networks (UZ Leuven, UZ Gent, Pius Hospital) and pharmaceutical partners (Sanofi, Novartis, AstraZeneca, Amgen). Platform is FDA-registered, CE-marked, ISO 13485 and ISO 27001 certified, GDPR compliant, and reimbursed in EU markets.

CORMAN s.p.a. is an Italian family-owned company founded in 1947, headquartered in Lacchiarella, Lombardy, and managed by its second generation. The company specializes in the production and global distribution of pharmaceuticals, medical devices, personal care products, and technical medical articles. Originally established as a textile dressing distributor, CORMAN has evolved into a market leader in Italy's pharmacy sector and personal care products worldwide. The product portfolio includes wound care dressings (Presteril brand), feminine hygiene products (Organyc®, Presteril Lady, Cottony), medical devices such as OMRON blood pressure monitors and aerosol therapy equipment, diagnostic tools (thermometers), and pharmacy-focused solutions. CORMAN operates specialized logistics through LOGICOR and maintains subsidiaries across the US, Europe, and China. The company emphasizes sustainability through patented processes that avoid chemical agents, minimize energy consumption and waste, and utilize geothermal, solar, and natural materials. With approximately 117 employees and estimated revenue of $15.6 million, CORMAN is committed to quality, innovation, and health initiatives supporting pharmacies, healthcare professionals, and consumers.

Aptar Digital Health, a division of Aptar Pharma and part of AptarGroup, Inc., is a comprehensive digital health solutions provider headquartered in Congers, New York. The company specializes in developing and deploying regulated digital therapeutics, companion mobile applications, and connected drug-delivery systems tailored for pharmaceutical and biotechnology partners globally. Aptar Digital Health operates across 120 countries with 20+ years of digital health leadership, supporting 15+ regulatory approvals and 17+ clinical studies. The platform is ISO 13485 and ISO 27001 certified, MDSAP-compliant, and adheres to HIPAA and GDPR standards. Core offerings include Software as a Medical Device (SaMD), Digital Patient Support Programs (PSPs), Disease Management Platforms, and Real-World Evidence generation services. Therapeutic focus areas encompass oncology, respiratory care, neurology (migraine, multiple sclerosis), immunology, and chronic disease management. The company's integrated platform enables pharmaceutical partners to enhance treatment adherence, optimize patient engagement across the entire treatment journey, and generate actionable clinical insights through connected devices and user community analytics.

MobileHelp is a leading provider of Personal Emergency Response Systems (PERS) and medical alert systems designed for seniors, chronic disease patients, and active adults. Founded in 2006, the company delivers 24/7 U.S.-based professional monitoring with rapid emergency response capabilities. MobileHelp offers a comprehensive range of solutions including in-home landline and cellular systems (Classic Landline, Classic Cellular), mobile wearable devices with GPS and fall detection (Solo, Micro), and bundled offerings (Home Duo, Mobile Duo) that combine home and mobile protection. All systems feature two-way voice communication, nationwide cellular and GPS technology, and AT&T connectivity options. The company emphasizes affordability with no equipment fees, no activation charges, and no long-term contracts, with pricing starting at $24.95/month. Additional services include MobileVitals telehealth platform and MobileHelp Connect for enhanced health management and care coordination, positioning the company as a comprehensive solution for independent living and emergency response.

MedMinder is a comprehensive digital healthcare platform specializing in medication adherence and connected care solutions for elderly patients, individuals with chronic illnesses, and those with cognitive or developmental impairments. Founded in 2007 and headquartered in Norwood, Massachusetts, the company provides an integrated ecosystem combining smart hardware, cloud-based software, pharmacy services, and remote monitoring capabilities. The MedMinder smart pill dispenser automates medication organization and delivery while generating actionable digital insights. The platform includes a user-friendly mobile app, secure cloud infrastructure, full-service digital pharmacy with prescription synchronization, and personalized data analytics. MedMinder serves providers, payors, and caregivers, enabling real-time medication tracking, remote monitoring, caregiver notifications, and improved communication between patients and clinical teams. The solution reduces medication errors, enhances medication compliance, supports independent living, and streamlines provider workflows while driving value-based care outcomes.

ROM Technologies, Inc. (ROMTech) is a medical technology company specializing in patented rehabilitation devices and telemedicine solutions for orthopedic and cardiac care. The company's flagship product, PortableConnect®, is a clinician-controlled medical device that delivers physical therapy sessions to patients at home, enabling accelerated recovery for those recovering from total knee replacement, total hip replacement, ACL repairs, and other arthroscopic procedures. ROMTech's telemedicine platform allows patients to begin therapeutic motion as early as the day of surgery, achieving range of motion recovery in approximately half the time of traditional physical therapy. Clinical outcomes demonstrate that PortableConnect patients meet or exceed pre-operative range of motion by 2 weeks post-surgery, with significant reductions in pain, narcotic usage, and hospital readmissions. The technology delivers substantial cost savings of $2,000–$6,250 per patient by reducing acute rehabilitation stays, home health visits, and outpatient therapy sessions while improving clinical outcomes. ROMTech has served over 90,000 patients nationally and has been recognized by Fast Company's 2025 Most Innovative Companies list and LexisNexis' Top 100 Global Innovators for 2026.

Onyx Healthcare USA is an FDA-registered, ISO 13485-certified medical technology company headquartered in Orange, California, with manufacturing operations in New Taipei City, Taiwan. With over 20 years of specialized experience, Onyx designs and manufactures medical-grade computing solutions and AI-ready platforms for healthcare providers, medical device manufacturers, and integrators. The company offers comprehensive OEM/ODM services, including custom medical device design, rapid prototyping, and production of UL 60601-1 certified computing systems. Product portfolio encompasses medical PCs, slim medical panel PCs, all-in-one workstations, bedside terminals, mobile computing carts with hot-swap batteries, medical tablets, medical displays, single-board computers, and accessories. Onyx specializes in AI-accelerated edge computing platforms featuring NVIDIA and Intel processors, supporting real-time medical imaging, surgical applications, and clinical inference. Additional offerings include hospital IT services, telemedicine solutions, mobile nursing stations, patient engagement systems, and the proprietary Orion Hospital IT Management Software. The company serves North American and Latin American healthcare markets with a focus on quality, regulatory compliance, and extended product longevity.

FuzeRx (operated by Truepill) is a URAC-accredited pharmacy and telehealth platform specializing in end-to-end digital pharmacy solutions for Life Sciences companies, payers, healthcare providers, and consumer health brands. The platform offers configurable APIs and white-label technology designed to streamline prescription fulfillment, patient management, and clinical data handling. FuzeRx provides three primary service models: Virtual Pharmacy (all-in-one platform combining hub and dispensing), Hub+ (automation-driven pharmacy hub with improved patient access and adherence), and Dispensing (specialty and brand medication fulfillment with nationwide 50-state shipping and same-day courier options). The platform processes over 25M prescriptions for 6M+ patients with 41% processed within 2 minutes. Deep therapeutic expertise spans women's health, endocrinology, and immunology. Features include configurable patient safety APIs for drug utilization reviews, customizable health questionnaires, insurance and FSA/HSA payment processing, custom branded packaging, and comprehensive data dashboards. URAC-accreditation ensures compliance with pharmacy and specialty pharmacy standards.

Rudolf Riester GmbH (Riester USA) is a German manufacturer of medical diagnostic devices established in 1948 and based in Jungingen, Baden-Württemberg. Part of Halma plc since 2007, Riester operates globally across over 150 countries with approximately 99 employees and $30.1 million in annual revenue. The company specializes in precision diagnostic and monitoring devices for primary care and specialist settings, including stethoscopes, blood pressure monitors, pulse oximeters, otoscopes, ophthalmoscopes, and digital medical camera systems. Riester also offers telemedicine solutions through strategic partnerships such as Docs in Clouds TeleCare GmbH, enabling remote healthcare delivery. The product portfolio emphasizes clinical accuracy, reliability, and innovation to support healthcare providers in improving patient outcomes across diverse clinical environments.

eKare Inc. is a digital health software company providing an integrated platform for advanced wound care management and clinical research. The company offers inSight, a CE-marked, FDA-registered wound measurement device that uses computer vision technology to capture accurate wound dimensions without reference markers. The platform combines advanced wound imaging, HIPAA and GDPR-compliant telehealth with real-time video conferencing and remote patient monitoring, clinical workflow optimization to reduce data entry burden, artificial intelligence developed by physicians for prognosis and outcome prediction, and business analytics dashboards for real-time clinical decision support. eKare serves healthcare organizations globally, from small clinics to Fortune 500 enterprises, with deployment across 56 countries. The solution integrates with major EHR systems including Epic, Cerner, and Medidata Rave via RESTful APIs and SMART on FHIR standards. Primary use cases include wound assessment standardization, patient engagement through automated alerts and secure messaging, clinical trial support with decentralized capabilities, and value-based care performance improvement. The company maintains regulatory compliance with FDA registration, CE marking, and data security certifications.